# GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes

> **NCT06630585** · PHASE3 · RECRUITING · sponsor: **University of Bern** · enrollment: 42 (estimated)

## Conditions studied

- Type 1 Diabetes (T1D)

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT06630585
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-14
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630585, "GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06630585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*